L-Ornithine L-Aspartate 5gm Injection in PCD pharma franchise in Hyderabad

L-Ornithine L-Aspartate 5gm Injection in pharmaceutical manufacturing company in Mumbai

L-Ornithine L-Aspartate 5gm Injection in liver care pharma franchise in Pune

L-Ornithine L-Aspartate 5gm Injection in pharma suppliers in Delhi

L-Ornithine L-Aspartate 5gm Injection in pharma export companies in Kolkata
L-Ornithine L-Aspartate 5gm Injection in pharma franchise opportunities in Bengaluru

Home/Products /l-ornithine-l-asparrtate-injection

About the Product

Description


 Hepalogy Injection contains L-Ornithine L-Aspartate (LOLA), a powerful hepatic detoxifier that plays a crucial role in improving liver function and reducing ammonia levels in patients suffering from liver disorders. It helps in the treatment of hepatic encephalopathy, fatty liver disease, and cirrhosis-related complications by enhancing the body's ability to eliminate toxins and supporting liver regeneration.

L-Ornithine L-Aspartate is an amino acid compound that works by converting ammonia into urea and glutamine, thereby reducing ammonia accumulation in the blood, which is a major cause of hepatic encephalopathy. This mechanism helps in reducing symptoms such as confusion, fatigue, and tremors associated with liver dysfunction.

Hepalogy Injection enhances liver metabolism, promotes detoxification, and supports overall hepatic function, making it an essential therapy for individuals with acute and chronic liver diseases. It is often used in hospital settings under medical supervision to ensure optimal liver support.

Possible side effects may include nausea, vomiting, stomach discomfort, and mild allergic reactions such as redness or swelling at the injection site. Rarely, dizziness or low blood pressure may occur.

Hepalogy Injection is indicated for the treatment of liver disorders, hepatic encephalopathy, cirrhosis, and conditions associated with high ammonia levels.

This injection should be administered only under medical supervision. Patients with severe kidney impairment should use it with caution. If any severe allergic reaction occurs, discontinue use and seek immediate medical attention.

Store at room temperature (below 25°C), away from direct sunlight and moisture. Do not freeze. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for L-Ornithine L-Aspartate Injection in the PCD pharma franchise market?

L-Ornithine L-Aspartate Injection has strong demand in the hepatology, critical care, and hospital segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on liver care and specialty medicine portfolios.

Why should medical distributors include L-Ornithine L-Aspartate Injection in their product range?

Medical distributors and agencies can benefit from consistent demand for liver-related conditions under specialist supervision. L-Ornithine L-Aspartate (LOLA) is commonly used to support ammonia detoxification in the body Frequently prescribed in the management of hepatic encephalopathy and other liver-related disorders as directed by healthcare professionals Widely utilized in hospitals and specialty liver-care settings This strengthens a reliable hepatology and critical-care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this injection?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for L-Ornithine L-Aspartate Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from specialist prescriptions, hospital demand, institutional supply opportunities, reliable supply chain support, and good margins in specialty injectable medicines.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing, product availability, and business terms, secure monopoly territory rights, and benefit from comprehensive marketing support, high-quality products, attractive profit margins, and a reliable supply chain to grow their pharmaceutical business successfully.